EACS 2007 11th European AIDS Conference / EACS
Madrid, Spain
October 24-27, 2007
Back to home » Top Stories » EACS 2007

emailrssprint

Children and Challenges: Treating Pediatric HIV

October 27, 2007

Over 2 million children are living with HIV/AIDS around the world. Dr. José Ramos talks with Peter Staley at the European AIDS Conference in Madrid about the challenges facing HIV-positive children and their health care providers, including treatment challenges with fewer approved antiretroviral options and limited dosing information.

 

9 1/2 minutes. Click here to view the transcript.

NEW! Scroll down to comment on this story.

emailrssprint


Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 4 (of 4 total)    

dorothy, birmingham, 2007-11-01 14:37:51
Thank you for this interview. Attention for pediatric HIV/AIDS is so sparse. It is important to remind ourselves there are perinatally infected children in the US too. Their parents, caregivers and the older children and adolescents, themselves, are hungry for information and support, but remain very 'closeted' for the most part.

Candie Haberman, JAcksonville, 2007-10-31 15:17:17
I have 2 HIV+ young boys. This was extremely interesting to me. Thank You. I wish there were more articles on pediatric HIV/AIDS.

Tim Horn, AIDSmeds.com, New York, 2007-10-30 10:17:11
Hi Beverly -- there's "therapeutic drug monitoring (TDM)" to measure levels of PIs and NNRTIs in your child's blood (measuring for NRTIs isn't useful). It's more common in Europe than in the U.S., however -- but talk with your child's pediatrician.

Beverly, Charlotte, NC, 2007-10-29 16:36:02
Can you explain how the test to measure the amount of medication absorbed by the body works? Would this test have any benefit to a child who has been treated for nearly 10 years and is currently undetectable? My concern might be overdosing as opposed to underdosing, especially regarding side effects to developing organs.

comments 1 - 4 (of 4 total)    


[Go to top]


October 27, 2007
New Menu of Antiviral Options
Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry, rilpivirine (TMC278) and the continued interest in Kaletra monotherapy.
Children and Challenges: Treating Pediatric HIV
Over 2 million children are living with HIV/AIDS throughout the world. Dr. José Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers.
October 26, 2007
Why Do Those With HIV Have More Heart Attacks?
HIV and its medications may increase the risk of cardiovascular disease, but Dr. Jens Lundgren tells Peter Staley that there's a lot to be said for preventive strategies.
Safer Family Planning for Positive Couples
Want to have a baby? Dr. Valerie Stone checks in with David Evans about family planning for couples living with HIV.
October 25, 2007
Aiming Low: 'Undetectable' Not Just for Treatment Newbies
Dr. Jonathan Schapiro tells Peter Staley that an undetectable viral load is almost always an obtainable goal, even for highly treatment-experienced patients with drug-resistant HIV.


© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy